Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
This explains the function of the index divisor for investors, including how it influences observed returns and analysis.
26,233 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
A war in the Middle East can push energy prices higher and disrupt global supply chains. This unintended consequence ...
A hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
When a founder sells a sizable stake, investors take note. This article digs into the implications of airbnb co-found...
As the quarterly earnings cycle wraps, universal (uve) 2025 earnings take center stage for growth-focused investors. ...
This oddity tech stock is making waves again. With a larger share repurchase plan and improving cash flow, the stock ...
Discover how Owens Corning 2025 earnings shape the stock's outlook. This guide breaks down Q4 results, margins, and t...
A major hedge fund reduced its Indivior stake by more than 2.2 million shares, signaling a shift in positioning. This...
A major director sale in a blockchain-focused company can raise questions about risk and opportunity. This deep dive ...
Coca-Cola has staged a remarkable rally this year, outpacing the broader market. Yet many investors wonder if this ri...